BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37005662)

  • 1. Neuroglobin plays as tumor suppressor by disrupting the stability of GPR35 in colorectal cancer.
    Xiang Q; Zhou D; Xiang X; Le X; Deng C; Sun R; Li C; Pang H; He J; Zheng Z; Tang J; Peng W; Peng X; He X; Wu F; Qiu J; Xu Y; Xiang T
    Clin Epigenetics; 2023 Apr; 15(1):57. PubMed ID: 37005662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis.
    Wu F; He J; Deng Q; Chen J; Peng M; Xiao J; Zeng Y; Yi L; Li Z; Tian R; Jiang Z
    Biochem Biophys Res Commun; 2023 Jul; 664():108-116. PubMed ID: 37141638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
    Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
    Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
    Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
    Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
    Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
    Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W
    Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer.
    Yuan Z; Yu X; Chen W; Chen D; Cai J; Jiang Y; Liu X; Wu Z; Wang L; Grady WM; Wang H
    Cell Commun Signal; 2022 Jul; 20(1):111. PubMed ID: 35870943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
    Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
    Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
    Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
    Kai M; Yamamoto E; Sato A; Yamano HO; Niinuma T; Kitajima H; Harada T; Aoki H; Maruyama R; Toyota M; Hatahira T; Nakase H; Sugai T; Yamashita T; Toyota M; Suzuki H
    Mol Carcinog; 2017 Jul; 56(7):1743-1752. PubMed ID: 28218473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis.
    Zhang B; Chang M; Wang J; Liu Y
    Biomed Pharmacother; 2017 Apr; 88():173-180. PubMed ID: 28103511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
    Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the 17β-estradiol pathways necessary for neuroglobin anti-apoptotic activity in breast cancer.
    Fiocchetti M; Cipolletti M; Ascenzi P; Marino M
    J Cell Physiol; 2018 Jul; 233(7):5087-5103. PubMed ID: 29219195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Neuroglobin Promotes Energy Metabolism and Autophagy Induction in Human Neuroblastoma SH-SY5Y Cells.
    Manganelli V; Salvatori I; Costanzo M; Capozzi A; Caissutti D; Caterino M; Valle C; Ferri A; Sorice M; Ruoppolo M; Garofalo T; Misasi R
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
    Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.